Dlgap5 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
.infobox .infobox-protein
{
float: right;
width: 300px;
padding: 10px;
background: #f8f9fa;
border: 1px solid #ddd;
border-radius: 4px;
margin: 10px;
}
.infobox .infobox-protein th
{
background: #28a745;
color: white;
padding: 8px;
}
.infobox .infobox-protein td
{
padding: 6px;
}
DLGAP5 Protein (DLGAP5) is a protein involved in cellular signaling and molecular processes. It is expressed in various tissues including the brain and plays roles in neuronal function and disease mechanisms.
DLGAP5 contains multiple repeats that mediate microtubule binding. The protein localizes to the mitotic spindle and kinetochores during cell division.
DLGAP5 (Dlg-associated protein 5, also called HURP) is a microtubule-associated protein that stabilizes spindle microtubules during mitosis. It is essential for proper chromosome segregation and cell division. DLGAP5 is upregulated in cancer and has been implicated in neuronal development.
DLGAP5 is overexpressed in various cancers. Its role in neurodegeneration is less clear, but altered cell division may affect neural stem cell function. DLGAP5 may be involved in DNA damage response.
No specific therapies target DLGAP5 in neurodegeneration. Microtubule-stabilizing agents (e.g., taxanes) may affect DLGAP5 function. Further research is needed to determine if DLGAP5 is a viable therapeutic target.
The study of Dlgap5 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.